Innovative Spinal Procedure and Collaboration Announced
Advancements in Spinal Fusion and Neuromodulation
SynerFuse™ and Velentium Medical are making exciting strides in the healthcare field by partnering to enhance spinal fusion and nerve stimulation procedures. Their recent collaboration focuses on scaling the ground-breaking SynerFuse™ e-TLIF™ procedure, which aims to integrate innovative technology with patient care.
Innovative Procedure Development
The completion of the clinical proof-of-concept study marks a pivotal moment for SynerFuse™ and Velentium Medical. Their combined efforts have resulted in the development of a procedure designed to improve patient quality of life significantly. "With this study finished, we are determined to enhance the lives of our patients through our innovative approaches," said a representative from SynerFuse™.
This e-TLIF™ technique will revolutionize the way spinal decompression and fusion are performed, primarily benefiting the over 500,000 individuals who endure traditional spinal fusion surgeries every year. Dan Purvis, Chairman and Cofounder of Velentium Medical, expressed excitement for this new treatment approach, signifying a substantial improvement in patient outcomes.
Strategic Partnership for Growth
Being selected as the strategic partner for SynerFuse™ enables Velentium Medical to showcase its superior capabilities in device design and manufacturing. Their new facility in Texas is committed to producing the e-TLIF™ devices, all while striving to create device technologies that change lives positively.
Dr. Rohan Lall, Chief Medical Officer of SynerFuse™, explained that the devices would be tailored by medical professionals specifically for addressing various forms of pain. The collaboration has emphasized the importance of integrating insights from clinical trials to refine the device further.
Clinical Insights and Patient Safety
Lowering patient risk is a priority in this new procedure. The SynerFuse™ e-TLIF™ therapy only requires a single incision, allowing surgeons to directly visualize and place the neurostimulation device. Dr. Michael C. Park, an Associate Professor of Neurosurgery involved in the study, applauded this method for bolstering patient safety.
Moreover, the therapy aims to combat issues associated with conventional spinal surgeries, such as ongoing neuropathic pain that can follow spinal fusion procedures. The integration of neuromodulation is anticipated to reduce patients’ reliance on opioids, addressing a significant healthcare challenge.
Understanding Chronic Lower Back Pain
Chronic lower back pain (cLBP) affects millions and often persists longer than 12 weeks. Research indicates that traditional spinal fusion methods come with risks, primarily the potential for residual neuropathic pain. The new SynerFuse™ therapy endeavors to offer an alternative, focusing on delivering effective pain management without the complications usually associated with opioids.
About the Partners
SynerFuse™ is based in Minnesota, specifically within the innovative Medical Alley, striving to provide new solutions for those dealing with chronic back pain. Their mission revolves around developing non-narcotic pain management alternatives that integrate technological advancements with traditional methods. They believe it's crucial to offer patients a choice beyond conventional spinal fusion.
On the other hand, Velentium Medical, located in Richmond, Texas, aims to manufacture safe and secure medical devices. This partnership signals a promising future not just for the two organizations, but for patients who seek relief from chronic pain conditions.
Frequently Asked Questions
What is the SynerFuse™ e-TLIF™ procedure?
The SynerFuse™ e-TLIF™ procedure integrates neuromodulation with spinal decompression and fusion, aimed at enhancing patient care and outcomes.
How does this procedure improve patient safety?
The procedure requires only a single incision and allows for direct visualization, minimizing risks associated with traditional methods.
Why is neuromodulation important in spinal surgery?
Neuromodulation can potentially reduce dependency on opioids while effectively managing neuropathic pain following surgery.
Who are the key partners in this collaboration?
SynerFuse™ and Velentium Medical have partnered to bring innovations to spinal fusion surgery, leveraging each other's expertise.
What is the long-term vision of SynerFuse™?
SynerFuse™ aims to provide a comprehensive solution for patients with chronic lower back pain, focusing on innovative pain management without narcotics.
About The Author
Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.